August 2022 - Page 24 of 25

TuesdayAug 02, 2022 11:15 am

Aditxt Inc. (NASDAQ: ADTX) Seeks to Address Variability of Immune Responses

Biotech innovation company, Aditxt, Inc (“Aditxt” or the “Company”) is developing and commercializing technologies focused on monitoring and reprogramming the immune system Their ground-breaking ADi(TM) immune reprogramming platform will be initially directed towards the treatment of psoriasis, type 1 diabetes and skin allografting The Company has also recently begun to commercialize their AditxtScore(TM) proprietary immune mapping technology, which is designed to provide individuals with personalized reports on their immune system The AditxtScore(TM) system is initially focused on providing customers with reports looking into their vulnerability and immune response to SARS-CoV-2 and its known variants Every 9 minutes, a person is…

TuesdayAug 02, 2022 10:00 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Surfs the Rising Wave of Metaverse Gaming

The popularity of online gaming is set to be further boosted through the advent of ‘Metaverse’ gaming Metaverse gaming allows for users to enhance their virtual gaming experience, interacting socially with their peers to mimic a realistic, casino experience in the comfort of their homes The development is also of great appeal to gaming providers, given the higher levels of transparency, security, and privacy involved relative to traditional casinos The growth in online gaming has spurred the creation of thousands of online gaming providers, with the vast majority opting to procure their operational systems from third-party ‘SaaS’ providers The trend…

TuesdayAug 02, 2022 9:30 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Enhances Business Certainty Through Long Term Offtake Agreement with Leading Utilities

EverGen boasts long term contracted offtakes with key energy providers such as FortisBC Offtakes mean that company has buyers lined up before production begins; these agreements are key in securing relatively stable and predictable cash flows 20-year offtake agreement with utilities like FortisBC enhances certainty for EverGen's business and allows it to build new production capacities to convert more organic waste into RNG Although a young company, EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF) appears poised to establish itself as one of the leaders in the renewable natural gas space (“RNG”) – especially in its home Canada. As a developer, owner…

TuesdayAug 02, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expanding Scope of Potentially Pivotal Study as Part of Clinical Program to Develop GBM Treatment

CNS Pharmaceuticals is undertaking a Berubicin clinical development program targeting glioblastoma multiforme (“GBM”), the most common and devastating primary malignant brain tumor GBM has an incidence rate of 3.21 per 100,000 in the U.S. and up to 5 per 100,000 globally, with studies noting that the latter figure is rising CNS recently received approval for a protocol amendment as part of its potentially pivotal study evaluating the efficacy and safety of Berubicin for the treatment of GBM The amendment expands eligibility for its potentially pivotal study to patients who have received additional treatments as part of the first-line therapy CNS…

MondayAug 01, 2022 1:54 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Scaling Solutions, Targeting Accretive Growth

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network (“LN”), is scaling solutions through the LN. “The company released its first node (US-West) in November 2021, alongside its platform-as-a-service (“PaaS”) offering, https://lqwd.tech. The current capacity of US-West is 6.06271656 BTC (606,271,656 sat/ US$118,154.83); it has over 100 active channels and connected nodes currently operational. Over the last 30 days, US-West has experienced an increase of 0.277324 BTC (+4.79%), an increase of six channels (+5.71%), and a median fee rate of 0.000003 sat. LQwD’s nodes currently operate across 17…

MondayAug 01, 2022 1:43 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) Sapientia Committed to Becoming Industry Leader in Snack Market

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) recently finalized the payment of $840,000, the last installment fulfilling all outstanding obligations toward the acquisition of Sapientia Technology LLC. “According to the company’s management, completing this milestone allows Sapientia to further collaborate with other Eat Well portfolio companies to increase its margins and expand its product lines and flavors. Since its acquisition, Sapientia has remained committed to becoming an industry leader in the snack market. It has created and filed four foundational patents revolving around the ‘Protein Twist’ and crispy puff style snack, capitalizing on the initial success of the protein…

MondayAug 01, 2022 1:35 pm

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) 360-Degree Offering Enables Ultimate ‘Anti-Label’ Solution

Friendable (OTC: FDBL) released the Fan Pass Live artist platform in July 2020. “Fan Pass Live allows independent artists to perform for and interact with fans without label control or costs. In January 2022, Friendable completed the acquisition of Artist Republik and FeaturedX to create the ultimate ‘anti-label,’ 360-degree solution for independent artists… With Artist Republik, artists can distribute their music, keep 100% of the royalties, and keep the rights to the music they produce. Artists receive royalty payouts quarterly, accessible through their Distribution Dashboard on the app. Artists are also afforded the opportunity to distribute and grow via Spotify…

MondayAug 01, 2022 12:00 pm

Cub Crafters Inc. Looking to Scale Up Operations with First Public Offering in Forty Years

Cub Crafters Inc. looks to take advantage of Regulation A to allow new public investment for scaling the company’s operations and attain the critical goal of continuing to innovate Once qualified to launch its public offering by the SEC, the company will offer its shares at $5 a share, with a minimum investment of $400 per investor CubCrafters looks to bank on the significant increase in backcountry flying, which has, in turn, driven up the demand for its aircraft The company’s management is confident that with this offering, the capital raised will enable it to achieve additional growth, delivering exceptional…

MondayAug 01, 2022 11:16 am

QualityStocksNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Names Industry Veteran as New COO

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance Micro Motion Technology(RM) (“MMT”) lidar solutions, has appointed Dr. Liqun Han as chief operating officer, a newly created role with responsibilities over the company’s product development and operations team. Han, a proven industry veteran, will continue to be in charge of the company’s flagship ADAS lidar program and will oversee and Cepton’s growing presence across automotive and smart infrastructure markets. Han joined Cepton in 2016 and has served as both vice president and senior vice president of operations, where he has led product development, commercialization and operational excellence teams;…

MondayAug 01, 2022 11:15 am

With People in Sports and Military Service Worried About Long-Term Consequences of Traumatic Brain Injuries, Odyssey Health, Inc. (ODYY) Is Working to Offer Relief with PRV-002 Concussion Drug

Players and military service members often retire with debilitating traumatic brain injuries (“TBIs”), including concussions, that lessen the quality of life and present neurological problems as they continue to age Odyssey has developed PRV-002, a novel compound for treating concussion, and a novel breath-propelled nasal delivery device for delivering the drug deep into the nasal cavity The PRV-002 drug is expected to offer reprieve to people suffering from concussion by potentially preventing long-term consequences of the condition The drug is currently undergoing evaluation as part of a Phase I study that has so far shown that it is well tolerated…

Site Search

Company Search

Month: August 2022